A potential mechanism of the onset of acute eosinophilic pneumonia triggered by an anti ‐PD‐1 immune checkpoint antibody in a lung cancer patient

ConclusionsGiven the increasing frequency of the use of anti ‐PD‐1 antibodies, clinicians should be aware of the risk of AEP as a potential irAE. This study may improve our understanding of the pathophysiology underlying Th2‐associated irAEs and AEP.

Source: Immunity, Inflammation and Disease - November 21, 2018 Category: Allergy & Immunology Authors: Takayuki Jodai, Chieko Yoshida, Ryo Sato, Yosuke Kakiuchi, Nahoko Sato, Shinji Iyama, Tomoko Kimura, Koichi Saruwatari, Sho Saeki, Hidenori Ichiyasu, Kazuhiko Fujii, Yusuke Tomita Tags: ORIGINAL RESEARCH Source Type: research